Skip to Content

News: Breast Cancer

HDL-cholesterol and breast cancer risk

Thursday, January 23rd, 2020

Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.

Study finds breast cancer recurrence score has different implications for men

Sunday, December 22nd, 2019

A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer

ACMG advises evaluating all breast cancer patients to determine the need for genetic testing

Friday, December 13th, 2019

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

Breast cancer research pioneer Page remembered

Thursday, October 24th, 2019

David Page, MD, former professor of Pathology and Preventive Medicine at Vanderbilt University School of Medicine, whose work revolutionized the assessment of breast cancer risk, died in Nashville on Thursday, Oct. 17. He was 78.

Pietenpol, Wilson land Komen cancer research support

Thursday, October 24th, 2019

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Another way to detect lymphedema

Tuesday, October 22nd, 2019

Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.

Study finds men have higher mortality rate after breast cancer diagnosis

Thursday, October 17th, 2019

A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.

Study backs genetic testing for all metastatic breast cancer patients

Friday, September 6th, 2019

Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

A “rheostat” for cancer signals

Friday, August 30th, 2019

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

Next Page »